Indiva
Indiva provide access to medical cannabis.
Launch date
Employees
Market cap
AUD6.6m
Enterprise valuation
AUD28m (Public information from Jun 2024)
Share price
CAD0.03 NDVA.V
London Ontario (HQ)
Financials
Estimates*
CAD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | <1m | 14.7m | 32.5m | 34.4m | 37.2m | 58.8m | 63.3m |
% growth | 1485 % | 1486 % | 122 % | 6 % | 8 % | 58 % | 8 % |
EBITDA | (9.5m) | (11.0m) | (11.0m) | (5.9m) | (1.9m) | 4.9m | 5.5m |
% EBITDA margin | (1027 %) | (75 %) | (34 %) | (17 %) | (5 %) | 8 % | 9 % |
Profit | (11.4m) | (15.4m) | (15.0m) | (10.9m) | (4.9m) | - | - |
% profit margin | (1234 %) | (105 %) | (46 %) | (32 %) | (13 %) | - | - |
EV / revenue | 31.0x | 3.0x | 2.2x | 1.0x | 1.0x | 0.6x | 0.5x |
EV / EBITDA | -3.0x | -3.9x | -6.4x | -5.9x | -19.8x | 6.8x | 5.6x |
R&D budget | <1m | <1m | <1m | 1.0m | - | - | - |
R&D % of revenue | 13 % | - | 1 % | 3 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $4.0m | Post IPO Debt | |
N/A | Acquisition | ||
* | $2.2m | Private Placement non VC | |
* | N/A | Acquisition | |
Total Funding | - |
Related Content
Recent News about Indiva
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.